0001213900-25-127129.txt : 20251231 0001213900-25-127129.hdr.sgml : 20251231 20251231162503 ACCESSION NUMBER: 0001213900-25-127129 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251231 DATE AS OF CHANGE: 20251231 EFFECTIVENESS DATE: 20251231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc. CENTRAL INDEX KEY: 0001937993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 880860746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568657 FILM NUMBER: 251617698 BUSINESS ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 306 CITY: PONTE VEDRA STATE: FL ZIP: 32082 BUSINESS PHONE: 904-300-0701 MAIL ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 306 CITY: PONTE VEDRA STATE: FL ZIP: 32082 D 1 primary_doc.xml X0708 D LIVE 0001937993 Cadrenal Therapeutics, Inc. 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 (904) 900-0701 DELAWARE None None Corporation true 2022 QUANG X. PHAM 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer Director Chief Executive Officer MATTHEW K. SZOT 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer Chief Financial Officer JEFFREY COLE 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer Chief Operating Officer JAMES J. FERGUSON 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer Chief Medical Officer STEVEN ZELENKOFSKE 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director GLYNN WILSON 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director JOHN R. MURPHY 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director LEE S. GOLDEN 822 A1A NORTH SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director Biotechnology Decline to Disclose 06b false 2025-12-16 false true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue New York NY NEW YORK 10022 FL FLORIDA IL ILLINOIS true 4396329 4396329 0 The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement. false 4 157501 true 0 Reflects commission paid in connection with a registered direct offering and this concurrent private placement. 0 false Cadrenal Therapeutics, Inc. /s/ QUANG X. PHAM QUANG X. PHAM Chief Executive Officer 2025-12-31